Conference
Cyclosporine-Induced Nephrotoxicity and Dose Adjustments in Bone Marrow Transplantation.
Abstract
Abstract
Background and hypothesis: Cyclosporine is administered to all patients undergoing allogeneic bone marrow transplantation in Hamilton. It is given intravenously at first then orally after engraftment. The manufacturer’s recommendation is to use a dose ratio of 1:3, IV to oral; the Hamilton unit uses a ratio of 1:2, yet has observed frequent rises of cyclosporine to toxic levels. We wished to confirm that the dose …
Authors
Piran S; Piran S; Stanley F; Walker I
Volume
108
Publisher
American Society of Hematology
Publication Date
November 16, 2006
DOI
10.1182/blood.v108.11.5233.5233
Conference proceedings
Blood
Issue
11
ISSN
0006-4971